Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Year in Review
  • Published:

Movement disorders in 2013

Diagnosing and treating PD—the earlier the better?

When the motor symptoms of Parkinson disease (PD) manifest, the underlying pathological processes have already caused irreversible damage. Research breakthroughs in 2013 support the importance of diagnosing PD in the prodromal phase, suggest biomarkers that could help in identifying patients at high risk of PD, and improve upon current deep brain stimulation strategies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Purchase on Springer Link

Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

References

  1. Cui, G. et al. Concurrent activation of striatal direct and indirect pathways during action initiation. Nature 494, 238–242 (2013).

    Article  CAS  Google Scholar 

  2. Lévesque, M. & Parent, A. The striatofugal fiber system in primates: a reevaluation of its organization based on single-axon tracing studies. Proc. Natl Acad. Sci. USA 102, 11888–11893 (2005).

    Article  Google Scholar 

  3. Recasens, A. et al. Lewy body extracts from Parkinson's disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys. Ann. Neurol. http://dx.doi.org/10.1002/ana.24066.

  4. Berg, D. et al. Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities. Lancet Neurol. 12, 514–524 (2013).

    Article  Google Scholar 

  5. Kordower, J. H. et al. Disease duration and the integrity of the nigrostriatal system in Parkinson's disease. Brain 136, 2419–2431 (2013).

    Article  Google Scholar 

  6. Iranzo, A. et al. Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. Lancet Neurol. 12, 443–453 (2013).

    Article  Google Scholar 

  7. Schapira, A. H. et al. Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial. Lancet Neurol. 12, 747–755 (2013).

    Article  CAS  Google Scholar 

  8. Schuepbach, W. M. et al. Neurostimulation for Parkinson's disease with early motor complications. N. Engl. J. Med. 368, 610–622 (2013).

    Article  CAS  Google Scholar 

  9. Sprenger, F., Seppi, K., Wolf, E. & Poewe, W. Relevance of EARLYSTIM in a tertiary movement disorder center. Mov. Disord. http://dx.doi.org/10.1002/mds.25631.

  10. Little, S. et al. Adaptive deep brain stimulation in advanced Parkinson disease. Ann. Neurol. 74, 449–457 (2013).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to François Tison.

Ethics declarations

Competing interests

The authors have received research grants from Novartis and served as advisory board members for Novartis Pharma France. In addition, F. Tison has served as an advisory board member for Abbott and Addex and W. G. Meissner has served as an advisory board member for Adaptive Neuromodulation. They have received teaching honoraria and travel grants from Boehringer Ingelheim, GlaxoSmithKline, TEVA/Lundbeck, Novartis, and UCB Pharma and W. Meissner has received funding from APTES and PSP-France.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tison, F., Meissner, W. Diagnosing and treating PD—the earlier the better?. Nat Rev Neurol 10, 65–66 (2014). https://doi.org/10.1038/nrneurol.2013.273

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2013.273

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing